SCHEMBL10143862

SCHEMBL10143862

Nc1ccc(OCCC(N)C(=O)OC2CCCC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 1/20 0.47
MAPK14 Q16539 2/20 0.46
MAPK13 O15264 1/20 0.46
MAPK12 P53778 1/20 0.46
MAPK11 Q15759 1/20 0.46
TDP1 Q9NUW8 1/20 0.44
STS P08842 4/20 0.36
CYP19A1 P11511 1/20 0.36
PARP10 Q53GL7 3/20 0.36
PARP15 Q460N3 2/20 0.36
LTA4H P09960 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
ALDH1A1 P00352 1/20 0.36
ACACB O00763 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13743683 1.00 NFE2L2 (0.47) NFE2L2MAPK14MAPK13MAPK12MAPK11
SCHEMBL1147939 0.88 SMN1; SMN2 (0.43) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL490765 0.88 SMN1; SMN2 (0.43) MAPK14MAPK13MAPK12MAPK11ALDH1A1
SCHEMBL5324639 0.84 MAPT (0.47) TDP1LTA4HPTGS1PTGS2HRH3
SCHEMBL5324642 0.84 MAPT (0.47) TDP1LTA4HPTGS1PTGS2HRH3
SCHEMBL12395416 0.83 TDP1 (0.43) NFE2L2MAPK14TDP1CYP19A1ALDH1A1
SCHEMBL14196755 0.82 MEN1 (0.51) MAPK14MAPK13MAPK12MAPK11TDP1
SCHEMBL5325622 0.81 NFE2L2 (0.44) NFE2L2TDP1CYP19A1ALDH1A1
SCHEMBL5325625 0.81 NFE2L2 (0.44) NFE2L2TDP1CYP19A1ALDH1A1
SCHEMBL191993 0.77 HDAC1 (0.48) LTA4HALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2079743-B1 PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER CHROMA THERAPEUTICS LTD (GB) 2012-01-25 EP disclosed
WO-2008050096-A1 PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER CHROMA THERAPEUTICS LTD. (GB) 2008-05-02 WO disclosed